A subchronic inhalation toxicity study of inhaled vapor grown carbon nanofibers (CNF) (VGCF-H
VGCF-H is a vapor grown carbon nanofiber (CNF), which has been formulated to enhance electrical and thermal properties of high-performance materials. VGCFs are produced by gas decomposition at high temperatures with metal catalysts initially acting as a nuclei center for carbon deposition and subsequent growth of the carbon fiber. Some commercial uses of this product include filler applications to enhance thermal conductivity and wear resistance in nanocomposites and to improve performance in batteries and fuel cells.
There are a number of existing carbon allotropes that result in different forms of carbon nanostructures. Some of these allotropic forms have been identified as diamond, graphite, fullerenes, graphene, amorphous carbon, and CNFs. CNFs and carbon nanotubes (CNTs) belong to the same family of carbon nano-objects and therefore have distinct similarities. As defined by The International Organization for Standardization (ISO), the nomenclature for CNFs also includes the family of CNT forms (Figs. 1A and 1B) . Although the CNFs and CNTs are derived from the same family of carbon nanostructure materials, there are considerable differences, which could have important toxicological ramifications. For instance, CNFs have measured Brunauer, Emmett, and Teller (BET) surface areas of ~14 m 2 /g, compared with multi-wall CNT (MWCNT) surface areas (> 200 m 2 /g). Moreover, CNTs have substantially greater aspect ratios than CNFs. In addition, because VGCF-H CNFs are subjected to high-temperature heat treatment during processing, they contain fewer catalyst residues. The reduced presence of metal catalysts on the CNF surface may limit the generation of reactive oxygen species (ROS) and inflammatory effects compared with catalyst-containing MWCNT.
The hazard database for inhaled single-wall CNT (SWCNT) and MWCNT effects in rats following subchronic exposures is rapidly emerging (Ma-Hock et al., 2009; Pauluhn, 2010) . In one of the first published subchronic inhalation studies with MWCNTs, Ma-Hock and coworkers exposed rats nose-only for 90 days to respirable samples of 0.1, 0.5, or 2.5 mg/m 3 Nanocyl MWCNT (90% carbon and 10% metal oxide; BETspecific surface area reported as 250-300 m 2 /g) and reported granulomatous-type inflammatory lesions in the lung and lymph nodes at the lowest exposure level tested (i.e., 0.1 mg/ m 3 ). A no-observed-adverse-effect level (NOAEL) from this study could not be identified (Ma-Hock et al., 2009) . In another study, Pauluhn exposed rats by inhalation for 90 days to a different form of MWCNT, Baytubes, at 0, 0.1, 0.4, 1.5, or 6 mg/ m 3 for 13 consecutive weeks. The measured BET surface area for the Baytubes was > 250 m 2 /g (containing 0.5% cobalt as a metal catalyst). The author reported lesions in the respiratory tract at concentrations ≥ 0.4 mg/m 3 , and 0.1 mg/m 3 was considered to be the NOAEL for this study (Pauluhn, 2010) . The results of the two subchronic inhalation studies indicate that the MWCNT samples produced potent pulmonary effects in rats at relatively low aerosol concentrations.
A long-standing and well-established concept of fiber toxicity has been developed over many decades, resulting from the findings of both animal inhalation toxicity studies and epidemiology health-based evaluations of workers in the mining and shipyard industries. In the aggregate, the findings have fostered a toxicological concept known as the "fiber paradigm" principles, which have been built historically upon the well-described database for asbestos toxicity studies (Donaldson et al., 2006 (Donaldson et al., , 2011 . Accordingly, it is recognized that repeated exposures to aerosols of long (> 15 µm), thin and durable/biopersistent fiber types ultimately produce sustained and progressive pathological effects in the respiratory tract. Following deposition, the pathological sequelae appear to be initiated by the occurrence of fiber-induced, persistent inflammatory/cytotoxic responses in alveolar regions of the lung. Repeated exposures facilitate a progression to fibroproliferative effects namely, septal lung fibrosis, hyperplasia, cell injury and turnover, and ultimately lung cancer (Donaldson et al., 2006 (Donaldson et al., , 2011 Warheit and DeLorme, 2012) . In attempting to discern the specific mechanisms of lung toxicity, it is widely regarded that fibrous particulates are more complex than nonfibrous particle types. This is because exposure-related adverse lung effects are strongly influenced by chemical composition, as well as physical factors, evidenced by the aspect ratio (i.e., ratio of fiber length/diameter) and durability of deposited fibers as a function of increased residence time in the pulmonary microenvironment. Donaldson and colleagues (2011) have referred to these particulates as high aspect ratio nanoparticles (HARNs), and it is suggested that the toxicity mechanism of HARNs will likely conform to the asbestos fiber toxicity paradigm. Therefore, this inhalation study with VGCF-H CNF represented an opportunity to gauge the relevance of this paradigm when compared with HARNs. Unlike some of the pathogenic, durable fibers, the VGCF-H sample is relatively short with an average length of 5.8 µm and, when inhaled, is likely to be readily phagocytized by resident alveolar macrophages. In contrast, longer exposures to durable fibrous particulate types are more resistant to normal lung clearance mechanisms and induce the pathological scenario described above. Because of these physicochemical differences with HARN prototypes, concomitant with reduced surface area metrics and diminished metal catalyst constituents, it was postulated that VGCF-H CNFs do not conform to the HARN-type fiber paradigm.
The aims of this 90-day inhalation study in rats were to (1) investigate the subchronic toxicity of inhaled VGCF-H CNFs; (2)
FIG. 1.
450 DELORME ET AL.
compare the CNF study results with those of other forms of carbon nano-objects such as MWCNTs; and (3) assess the relevance of the VGCF-H CNF test substance for comparisons with the "HARN-type" fiber toxicity paradigm using standardized testing methodology. Previous studies in rats had indicated that VGCF-H has low acute inhalation toxicity; however, the effects of longterm exposure to this test substance were unknown. At the conclusion of the exposure period, an additional recovery period of approximately 3 months was included in the study protocol for selected groups to determine the persistence of any measured toxic effects identified at the end of the 90-day exposure period. The inhalation route was selected because of its relevance for human exposure in the workplace. In addition to the standard toxicological assessments and particular focus on the characterization of the test substance, this study provided a useful barometer to assess impacts of exposure-induced pulmonary effects among different carbon allotropes, by comparing the effects of inhaled CNFs relative to the findings reported by other investigators with aerosolized MWCNTs in rats. This paper describes the first 90-day inhalation toxicity study findings in rats with CNFs.
MATERIALS AND METHODS
Objective. The objective of this study was to evaluate the inhalation toxicity of well-characterized test samples of VGCF-H CNFs in groups of male and female rats over a 90-day period based on OECD 413 and OPPTS 870-3465 testing methodologies. In addition to the standard toxicological endpoints specified in the OECD guidelines, particular attention was focused on potential effects occurring in the alveolar and pleural regions of the respiratory tract. Accordingly, bronchoalveolar lavage (BAL) and 5-bromo-2΄-deoxyuridine (BrdU) cellular proliferation investigations of terminal bronchiolar, lung parenchymal, and subpleural regions of the respiratory tract were implemented. The development of these additional sensitive endpoints served to provide greater mechanistic insights into the interpretation of the study findings.
Test substance. The test substance, VGCF-H CNFs, was supplied by the sponsor, Showa Denko KK, Tokyo, Japan. The chemical composition of CNF was > 99.5% carbon, 0.03% oxygen and contained a metal catalyst residue of < 0.003% iron. The chemical contents were determined using LECO CHNS-932, LECO TC-600 (Leco Corporation, St Joseph, MI) inductively coupled plasma atomic emission spectroscopy analyzers (Vista-pro model, SII Nano Technology Inc., Chiba, Japan). The purity of the test material was > 99.7%. The BET measured specific surface area dimension of VGCF-H CNFs was determined to be 13.8 m 2 /g. Surface area was determined with a NOVA 1200 (Quantachrome Instruments) BET surface analyzer. To quantify the length and dimension distributions of the bulk test substance, filters containing VGCF-H were prepared for scanning electron microscopy (SEM). The average lengths and diameter dimensions of CNFs were assessed by counting > 300 nanofibers (for each dimension) by utilizing SEM techniques (magnification for lengths ×10,000; and magnification for diameters ×20,000) with calibrated scanning electron microscopes (JEOL JSM-6390 and JEOL JSM-7000F). The measurement included a fiber size distribution analysis, and the average values were calculated to be 5.8 µm in length (range of 1-14 µm) and 158 nm in diameter (range of 40-350 nm).
Animals. Pathogen-free male and female Crl:CD Sprague Dawley rats were received from Charles River Breeding Laboratories (Raleigh, NC) and were approximately 5 weeks old on the day of arrival. All procedures using animals were reviewed and approved by Haskell's Institutional Animal Care and Use Committee, and the animal program is fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care.
Exposure system. Chamber atmospheres were generated by metering the test substance into a glass tube (approximately 1 inch in diameter and approximately 10 inches long) using either Accurate model 102M or 106M bin feeders; a filtered, high-pressure air stream (generation air) carried the resulting atmosphere into the exposure chamber. A dilution air stream of filtered, high-pressure air entered the exposure chamber near the test substance inlet. For the 0.54 and 2.5 mg/m³ exposure levels, a timer was connected to the bin feeder and chamber concentrations were controlled by varying the test substance feed rate into the air stream, by varying either the dilutional or generation air flows or by varying the timer on/off period. Test atmospheres were generated dynamically using airflows of at least 55 l/min, which resulted in 22 air changes per hour in the exposure chambers. The exposure chamber was constructed of stainless steel and glass (NYU Style) with a nominal internal volume of 150 l. Preliminary chamber validation studies demonstrated that the test substance was evenly distributed in the breathing zone of the animals. During exposure, animals were individually restrained in perforated stainless steel cylinders with conical nose pieces. The restraint tubes were inserted into a polymethylmethacrylate faceplate attached to the exposure chamber so that the nose of each animal extended into the exposure atmosphere. Prior to the start of animal exposures, animals were acclimated to the nose-only restraint tubes on two separate days.
Exposure atmosphere characterization. During each exposure, the atmospheric concentration of the test substance was determined by gravimetric analysis; two times for 0.54 mg/m³; four times for 2.5 mg/m³; and six times for the 25 mg/m³ atmospheres. Known volumes of chamber atmosphere were drawn from the sampling port through a 25 mm filter cassette containing a preweighed glass fiber (Type A/E) filter. The filters were weighed on a Cahn model C-30 Microbalance, and the atmospheric concentrations of VGCF-H calculated from the difference between the pre-and postsampling filter weights divided by the volume of chamber atmosphere sampled. The control chamber was air sampled once each week during the exposure phase of the study. Air samples to determine the number of fibers per cubic centimeter of air (f/cc) in the exposure atmosphere were also collected and analyzed based on criteria established in the NIOSH Manual of Analytical Methods 7400-Asbestos and Other Fibers by Phase Contrast Microscopy (NIOSH, 1994) . Samples to determine the mass median aerodynamic diameter (MMAD) and geometric standard deviation (GSD) were taken once each week from the exposure chambers using a Sierra series 210 cyclone preseparator/cascade impactor and Sierra series 110 constant flow air sampler. Air samples collected on polycarbonate filters were evaluated by SEM and transmission electron microscopy (TEM) to further assess the exposure atmosphere.
General experimental design. The design of this study was based on the OECD testing guideline 413 (OECD, 1991) and EPA OPPTS 870.3465 (U.S. EPA, 1998). Four groups each of 25 male and 25 female Sprague Dawley rats were exposed nose-only, 6 h per day, for 5 days per week to target concentrations of 0.50, 2.5, or 25 mg/m 3 VGCF-H CNFs for 13 weeks over a 90-day period for a total of 65 exposures. Groups of 10 animals per sex from all exposure levels were sacrificed 1 day following the final exposure (subchronic toxicity group) in addition to a recovery group of 10 males and 10 females exposed to 0 or 25 mg/m 3 that were evaluated at 3 months postexposure (PE) to determine the reversibility of any toxic effects. Body weight and food consumption parameters were determined weekly, and clinical signs of toxicity were monitored throughout the study. One day following the final exposure, blood and urine samples were collected from 10 animals per sex per exposure group and were analyzed for standard clinical, chemical, and hematological endpoints. Animals were then sacrificed, necropsied, and examined for gross and microscopic pathology evaluations. In addition to the standard endpoints promulgated by OECD and OPPTS, groups of five animals per sex per exposure level were sacrificed 1 day following the final exposure for BALF and CP studies. The previously discussed endpoints were also performed on animals exposed to 0 and 25 mg/m³ following the 3-month recovery period.
BAL.
Groups of five animals per sex per exposure concentration were sacrificed for BALF analyses, the methodology and analysis of which have INHALATION TOXICITY STUDY WITH A VAPOR GROWN CARBON NANOFIBER been previously reported (Warheit et al., 1997) . Briefly, animals were euthanized by ip pentobarbital injection and exsanguination. The lungs of rats were lavaged with a phosphate-buffered saline (PBS) solution, cells counted and the first 12 ml of lavaged fluids recovered from the lungs of rats centrifuged at 700 g, and ~2 ml of the supernatant was removed for biochemical studies. All biochemical assays were performed using an Olympus AU640 clinical chemistry analyzer. Lactate dehydrogenase (LDH) is a cytoplasmic enzyme and was used as an indicator of cell injury. Alkaline phosphatase (ALKP) activity is a measure of type II alveolar epithelial cell secretory activity, and increased ALKP in BAL fluids was considered to be an indicator of type II lung epithelial cell toxicity. Increases in BAL fluid microprotein (MTP) concentrations generally were consistent with enhanced permeability of vascular proteins into the alveolar regions, indicating a breakdown in the integrity of the alveolar-capillary barrier. In addition, semi quantification of pulmonary macrophage phagocytosis of CNFs was conducted by determining the percentages of macrophages containing test material in the BAL cytocentrifuge preparations at 1000× magnification. At least 200 cells/slide were evaluated for macrophages containing CNFs. The criterion for phagocytosis was determined to be either positive or negative, and the degree or burden of particulates was not assessed.
Cell proliferation studies. The methods for conducting cell proliferation (CP) studies with BrdU as well as different regions of the respiratory tract have been previously described (Warheit, 2009; Warheit et al., 1996) . Briefly, groups of five rats per sex per exposure group designated for subchronic toxicity and recovery each were pulsed with an intraperitoneal injection of 100 mg/kg body weight of BrdU (Sigma Aldrich Co., St Louis, MO) dissolved in 0.5N PBS solution 6 h prior to euthanasia. Following cessation of spontaneous respiration, the lungs were infused with a neutral-buffered formalin fixative, the trachea was clamped and then immersed in formalin. In addition, a 1-cm piece of duodenum (which served as a positive labeling tissue control) was removed and stored in formaldehyde. Subsequently, parasagittal sections from the right cranial and caudal lobes and regions of the left lung lobe, as well as the duodenal and heart muscle sections were dehydrated in 70% ethanol and sectioned for histology. The sections were embedded in paraffin, cut, and mounted on glass slides. The slides were stained with an anti-BrdU antibody (Becton Dickinson, San Jose, CA), with 3-amino-9-ethyl carbazole (AEC) marker (Vector Labs., Burlingame, CA) and counterstained with aqueous hematoxylin. A minimum of 500-1000 cells/animal were counted each in the following areas of the lung: (1) terminal bronchiolar regions; (2) lung parenchymal regions; (3) subpleural regions; and (4) mesothelial cells on the visceral pleura. The terminal bronchiolar regions were defined as terminal bronchiolar epithelial cells proximal to alveolar ducts. The lung parenchymal regions were defined as those cells commencing distal to the terminal bronchiolar region/first alveolar duct bifurcation (i.e., centriacinar) and were randomly counted as one moved distally. The subpleural/mesothelial region was defined as the cells contained within the last alveolar duct region adjacent to the visceral pleura surface, concomitant with mesothelial cells lining the visceral pleural surface. Ninety percent of the cells counted were in the subpleural region, and 10% of the cells were identified as mesothelial cells on the visceral pleural surface.
Statistical analysis.
Significance was judged at the p < 0.05 level. Separate analyses were performed on the data collected for each sex. If the Shapiro-Wilk test was not significant but Levene's test was significant, a robust version of Dunnett's test was used. If the Shapiro-Wilk test was significant, Kruskal-Wallis test was followed by Dunn's test. For analyses of the BAL fluid and cellular proliferation data, each of the experimental values was compared with their corresponding sham control values for each time point. A one-way analysis of variance (ANOVA) and Bartlett's test were calculated for each sampling time. When the F-test from ANOVA was significant, the Dunnett's test was used to compare means from the control group and each of the groups exposed to CNF. SAS Release 8.02 TS Level 02M0 was used for this analysis.
RESULTS

Chamber Atmosphere Characterization of VGCF-H
The low exposure group was exposed to a gravimetrically determined aerosol concentration of 0.54 ± 0.018 mg/m³ (mean ± SEM) that was characterized by a MMAD (GSD) of 1.9 µm (3.1) and a fiber count of 4.9 fibers/cc. The intermediate exposure group was exposed to 2.5 ± 0.039 mg/m³ that was characterized by a MMAD of 3.2 µm (2.1) and a fiber count of 56 fibers/cc. The high exposure group was exposed to 25 ± 0.33 mg/m³ that was characterized by a MMAD of 3.3 µm (2.0) and a fiber count of 252 fibers/cc (Table 1) . Examination of the filters collected for fiber counts demonstrated that the test material existed both as single fibers as well as clumps in the exposure atmospheres (Fig. 2) . Only those fibers where both ends could be visualized and met the criteria as promulgated in the NIOSH 7400 method were counted. SEM and TEM evaluation of the exposure atmosphere also demonstrated a complex mixture of agglomerated and single fibers (Fig. 3) . Overall, the atmospheres that animals were exposed to were in the respirable range and were considered adequate for evaluating the toxicity of the test material. Notes. Gravimetric results represent the mean ± SEM (n = 131-394); MMAD data represent the mass median aerodynamic diameter (geometric standard deviation, GSD) (n = 13-15); fiber counts represent the mean ± SD (n = 9-12). N.M., not measured.
FIG. 2.
Low-magnification light micrograph of a filter used for counting aerosolized VGCF-H carbon nanofibers. Note that some of the particulate test material had agglomerated and made the fiber counts difficult. Magnification 400×.
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Toxicity Observations
Exposures to CNFs did not result in biologically significant changes versus controls in body weights or food consumption parameters. Although body weights of male rats exposed to 0.54 mg/m 3 were statistically lower than its respective air control value, this difference was less than 15% and did not demonstrate a concentration-response relationship and therefore was not considered adverse (Table 2A ). There were no adverse clinical signs of toxicity observed in this study, and no effects were observed in the ophthalmological evaluations. Gross histopathological evaluations revealed a concentration- Male rats exposed to 25 mg/m³ demonstrated significant elevations in wet lung weights when compared with the air control group at 1 day PE and remained elevated following the 3-month recovery period. Female rats exposed to 2.5 and 25 mg/m³ also demonstrated significant elevations in wet lung weights (15% increase vs. controls for the 2.5 mg/m 3 group) at 1 day post 90-day exposure and remained significantly elevated in the 25 mg/m³ exposure group following 3 months of recovery (Table 2B ). The observed statistical increases in wet lung weights correlated with the lung to brain weight ratio determinations (Table 2C ), indicating that the altered wet lung weights were not due to dehydration or adverse alterations in terminal body weights.
Microscopic Histopathology
Inflammatory lesions in the lung were graded on a scale of 1-4 depending on severity (e.g., 1 = minimal; 2 = slight; 3 = moderate; and 4 = marked). Exposure of male and female Sprague Dawley rats to concentrations of 0.54, 2.5, or 25 mg/m 3 of VGCF-H resulted in a concentration-related accumulation of fibers within alveolar macrophages and, at the two highest exposure concentrations, a subacute to chronic inflammation of the terminal bronchiole and alveolar duct areas of the lungs. No adverse effects were observed at 0.54 mg/m 3 . There was observed minimal inflammation of the terminal bronchiole and alveolar duct areas in rats exposed to 2.5 mg/m³ VGCF-H (i.e., grade 1 for 7/10 males and 7/10 females). In rats exposed to 25 mg/m³ CNF, slight subacute to chronic inflammation of the terminal bronchiole and alveolar duct areas of the lungs was observed, with some thickening of interstitial walls and hypertrophy/hyperplasia of type II pneumocytes (i.e., grade 2 for 10/10 males and females each; Figs. 4A and 4B). After a 3-month recovery period, the numbers of fiber-laden alveolar macrophages and inflammation still persisted in the lung but were reduced in rats exposed to the high concentration.
A nonspecific reaction to exposure of the nasal passages resulted in the appearance of eosinophilic hyaline droplets in the nasal mucosa, which were considered an adaptive and nonadverse response. Fibers were also noted in the nasal turbinates in all rats exposed to the highest concentration. At the highest exposure level, this finding also persisted after the 3-month recovery period. Fiber translocation from airspace to mediastinal lymph nodes was observed for all CNF exposure groups but was not quantified.
Extrapulmonary fibers rarely were identified in the brain, heart, liver, kidneys, spleen, intestinal tract, kidneys, and mediastinal lymph nodes; however, no adverse histopathological effects were observed in any extrapulmonary organs wherein CNFs had translocated. Therefore, this finding was considered nonadverse.
Under the conditions of this study, the histopathological NOAEL for VGCF-H was considered to be 0.54 mg/m³ (4.9 fibers/cc) for male and female rats. This was based on the minimal inflammation observed in terminal bronchioles and alveolar ducts of male and female rats exposed to 2.5 mg/m 3 VGCF-H. At the 25 mg/m 3 exposure level, morphological evaluations revealed slight subacute to chronic inflammation of the terminal bronchiole and alveolar duct areas of the lungs with some thickening of interstitial walls and hypertrophy/hyperplasia of type II pneumocytes in rats.
BAL Studies
The number of cells recovered by BAL from the lungs of CNF-exposed rats was not significantly higher than any of the other groups for the subchronic 90-day exposure period or in the recovery group (Table 3) . Inhalation exposures to VGCF-H nanofibers produced small but significantly increased neutrophilic inflammatory responses in both male and female rats at 25 mg/m³ exposures wherein ~11-12% polymorphonuclear leukocytes (PMNs) were measured (Figs. 5A and 5B). Following the 3-month recovery period, the inflammatory response in male rats exposed to 25 mg/m³ was considered to be relatively minor but still significantly (Table 2A) terminal body weight, (Table 2B ) wet lung weights, and (Table 2C ) lung/brain weight ratios.
Results represent the mean ± SD (n = 10) of weights determined at the time of necropsy. *p < 0.05, statistically different from the respective air control value. increased when compared with the air control group (Fig. 5) , indicating that the inflammatory response measured in the subchronic toxicity group had not resolved following the 90-day recovery period. Exposures to 0.54 or 2.5 mg/m³ did not produce significant differences in neutrophilic inflammation when compared with air-exposed controls (Fig. 5A , Table 3 ). Greater than 60% of CNF-exposed pulmonary macrophages recovered in BAL fluids from the 0.5 mg/m³ exposure group
FIG. 4.
Lung tissue sections from a male rat exposed to 25 mg/m 3 VGCF-H carbon nanofibers for 90 days. Note the slight inflammation and macrophages accumulating in alveolar ductal areas (4A; 100× magnification). 4B demonstrates the presence of macrophages that have phagocytized VGCF-H in the alveolar region (arrows) as well as thickened duct walls; 1000× magnification. 
TABLE 3A BAL Cell Differentials-Male
TABLE 3B BAL Cell Differentials-Female
Exposure concentration
Total Cells (× 10 6 ) % Macrophage % PMN % Lymph % EOS % BIN 1-day postexposure 0 mg/m³ (air control) 8.45 ± 1.66 96 ± 0.98 0.81 ± 0.64 0.00 ± 0.00 0.00 ± 0.00 3.0 ± 0.36 0.54 mg/m³ 8.60 ± 0.656 96 ± 1.3 0.21 ± 0.14 0.00 ± 0.00 0.00 ± 0.00 4.1 ± 1.3 2.5 mg/m³ 9.14 ± 0.509 92 ± 2.2 2.1 ± 1.4 0.10 ± 0.090 0.00 ± 0.00 5.5 ± 1.1 25 mg/m³ 10.6 ± 0.957 80 ± 4.0 12 ± 5.1* 1.4 ± 1.1 0.00 ± 0.00 6.4 ± 0.37 3-month postexposure 0 mg/m³ (air control) 8.41 ± 0.809 97 ± 0.90 0.37 ± 0.31 0.16 ± 0.22 0.00 ± 0.00 2.4 ± 0.72 25 mg/m³ 8.01 ± 0.859 84 ± 2.6 7.1 ± 1.9 0.84 ± 0.89 0.00 ± 0.00 7.9 ± 0.97
Note. Results represent the mean ± SD (n = 5) of inflammatory cells recovered by BAL 1-day and 3-month postexposure for male (Table 3A) and female (Table 3B) contained nanofibers (male and females). In addition, > 90% of macrophages in the 2.5 and 25 mg/m³ groups contained nanofibers. After a 3-month recovery period, > 70% of macrophages from the 25 mg/m³-exposed group contained nanofibers, suggesting that some of the test material was cleared from the conducting airways (Fig. 6) . One day following the final exposure, BAL fluid LDH, ALKP, and MTP levels were significantly elevated in both male and female rats exposed to 25 mg/m³ CNF. No alterations were noted in animals exposed to 0.54 or 2.5 mg/m³ versus air-exposed controls. Following the 3-month recovery period, the BAL fluid levels of LDH, ALKP, and MTP were still significantly elevated in animals exposed to 25 mg/m³ except for the ALKP in females, which was not significantly different from that of the air-exposed control group (Tables  4A and 4B ).
FIG. 6.
Results represent the mean ± SD (n = 5) of the percentage of macrophages containing VGCF-H test material. No attempts were made to quantify the number of fibers in the macrophage or rank the level of burden in the macrophage. It is noteworthy that the percentage of macrophages containing VGCF-H decreased following the 3-month recovery period, suggesting some clearance of test material from the lung.
TABLE 4A BAL Chemistry-Males
Exposure group LDH (U/l) MTP (mg/dl) ALKP (U/l) 1-day postexposure 0 mg/m³ (air control) 44 ± 13 13 ± 2 47 ± 6 0.54 mg/m³ 44 ± 10 13 ± 3 49 ± 9 2.5 mg/m³ 63 ± 16 17 ± 3 58 ± 8 25 mg/m³ 123 ± 17* 27 ± 2* 75 ± 9* 3-month postexposure 0 mg/m³ (air control) 45 ± 10 13 ± 2 57 ± 9 25 mg/m³ 105 ± 21* 24 ± 3* 80 ± 15*
TABLE 4B BAL Chemistry-Females
1-day postexposure 0 mg/m³ 38 ± 8 13 ± 3 45 ± 11 0.54 mg/m³ 37 ± 8 13 ± 1 50 ± 5 2.5 mg/m³ 57 ± 19 14 ± 3 51 ± 14 25 mg/m³ 109 ± 22* 24 ± 4* 65 ± 9* 3-month postexposure 0 mg/m³ 41 ± 9 11 ± 2 56 ± 17 25 mg/m³ 80 ± 11* 21 ± 4* 63 ± 10
Note. Results represent the mean ± SD (n = 5) of BAL chemistry values measured in male (Table 4A ) and female (Table 4B) 
FIG. 5. (A)
Data represent the mean ± SD (n = 5) of the percent PMNs recovered from the BAL of male and female rats exposed to VGCF-H. Asterisks indicated significantly different from the respective air control group, p < 0.05. (B) is the cytocentrifuge preparation of cells recovered by bronchoalveolar lavage from a male rat exposed to 25 mg/m 3 VGCF-H CNFs. Note the minor inflammatory response as represented by ~11% neutrophils. Greater than 90% of the macrophages were phagocytic, that is, containing VGCF-H. 456 DELORME ET AL.
Pulmonary CP Studies
Significant increases in CP of the tracheobronchial, parenchymal, and subpleural regions, as determined by increased BrdU immunostaining, were observed in both male and female rats 1 day following the final exposure to 25 mg/m³ VGCF-H. No increase in CP was noted in animals exposed to 0.54 or 2.5 mg/m³ test material (Tables 5A and 5B ). Following a 3-month PE period, 25 mg/m 3 -exposed male rats demonstrated no significant differences from the air control group in BrdU staining in all areas of the lung tissue (Table 5A) . BrdU staining of lungs in female rats following the 3-month recovery period also demonstrated a reversal in CP endpoints except in the subpleural region (Table 5B) , which was still elevated when compared with the air control group at this time point. Virtually, all of the increased CP indices were associated with positive staining cells located in distal alveolar ducts adjacent or subadjacent to the visceral pleura, generally located in proximity to particulate-containing macrophages. No significant increase in immunostained cell labeling relative to controls was measured in mesothelial cells for any of the exposed groups (data not shown). In addition, no VGCF-H nanofibers were observed interacting directly with mesothelial cells.
DISCUSSION
The confluence of BAL fluid, CP, and histopathological endpoints used to identify pulmonary toxicological effects in male and female rats exposed to the highest concentration tested (i.e., 25 mg/m 3 ) was clearly in agreement. However, the adverse effects observed in rats exposed to 2.5 mg/m 3 CNF were less defined, as evidenced by the divergence of results when comparing histopathological observations versus BAL fluid and CP measurements. Specifically, histopathological observations revealed a minimal inflammatory response in the terminal bronchiole and centriacinar regions of the respiratory tract. In contrast, no significant quantitative differences were measured between control values and rats exposed to 2.5 mg/ m 3 with respect to other, sensitive measured endpoints (BAL fluid analyses and CP). BAL fluid results for both male and female rats in the 2.5 mg/m 3 group demonstrated no differences versus controls in comparing neutrophilic inflammation or lung cytotoxicity endpoints (BAL fluid LDH, MTP, and ALKP values vs. controls); CP assessments likewise revealed no increases versus controls in terminal bronchiolar, lung parenchymal, subpleural, or mesothelial cell labeling indices. The interpretation of these data would indicate an absence of cellular injury or repair in any of the respiratory tract compartments exposed to 2.5 mg/m 3 VGCF-H nanofibers. Moreover, a broader consideration of the apparent divergent results between histopathological analyses and BAL fluid + CP data raises important issues regarding the standards for interpretation of adverse results and the corresponding toxicological endpoint criteria when establishing (adverse) effect levels for subchronic inhalation studies with aerosols. Specifically, there is a question of whether some findings should be interpreted as biological adaptations versus adverse effects. Accordingly, it is recommended that greater consideration be given to a weight-of-evidence approach for establishing effect levels. The criteria necessary to formulate these values require meaningful deliberation and full discourse among toxicologists, pathologists, and other scientific professionals. In the absence of this important discussion, the investigators have taken a conservative approach for this study and have deemed the effect level for aerosolized VGCF-H to be 2.5 mg/m 3 , based on a small increase in female lung weights (> 15% vs. controls), and histopathogical assessments of minimal inflammation of the terminal bronchiole and alveolar duct areas.
Although CNTs and other carbon allotropes have unlimited potential for a variety of commercial applications, successful development will require strict Environmental Health and Safety assurances. Therefore, CNTs are undergoing intense regulatory scrutiny, often requiring 90-day inhalation toxicity and worker exposure studies as a prerequisite for the determination of regulatory acceptance. Some recent, well-conducted subchronic inhalation studies with CNTs in rats have set important precedents for assessing pulmonary hazard effects (MaHock et al., 2009; Pauluhn, 2010) . The studies were of high (Table 5A ) and female (Table 5B) quality and competently conducted under standardized OECD 413 guidelines. However, it has been suggested that the experimental design of future studies could be expanded to provide additional mechanistic insights beyond the traditional and required OECD toxicity endpoints (Warheit, 2009) . Specifically, four additional relevant issues were considered in the experimental design of this 3-month inhalation study:
1. Were the adverse effects measured at the high-concentration exposure sustained?
2. Do the physicochemical characteristics of the CNFs influence the toxicity results?
3. What are the potential cardiovascular (i.e., extrapulmonary and systemic) effects of inhaled CNFs?
4. Do inhaled CNFs produced pleural effects as has been alleged for some forms of CNTs?
The pulmonary toxicity database for CNTs has rapidly emerged since the onset of the initial, intratracheal instillation studies with SWCNTs and MWCNTs were first reported in -2005 (Lam et al., 2004 Muller et al., 2005; Warheit et al., 2004) . The results of the earlier studies indicated that CNTs were potent pneumotoxicants in the lungs of rodents at relatively low exposure concentrations. They served as a harbinger for the recently reported, more physiologically relevant, subchronic inhalation toxicity studies with MWCNTs. Ma-Hock et al. The mean tube lengths, as measured by TEM, were reported to be 200-300 nm, and the BET surface area was measured in the range of 255 m 2 /g. Histopathological lesions in the lower respiratory tract, characterized by cellular inflammatory alterations and interstitial collagen staining were reported to occur at 0.4, 1.5, and 6.0 mg/m 3 exposure levels. The NOAEL was determined to be 0.1 mg/m 3 (Pauluhn, 2010) . Morimoto et al. (forthcoming) studied the lung toxicity of well-dispersed MWCNT in rats following 4-week inhalation or intratracheal instillation exposures. The MWCNT test samples were artificially dispersed in a solution and then aerosolized (single concentration: 0.37 mg/m 3 for 4 weeks) or instilled into the lungs of rats (0.1 or 0.2 mg). Physicochemical characteristics of the MWCNT (Nikkiso Co.) were reported as mean diameter of 44 nm, length of 1.1 µm, and BET surface area of 69 m 2 /g. The investigators reported that MWCNT instillation exposures induced pulmonary inflammation (persistent in the high-dose group) and small granulomatous lesions. Inhalation exposures produced less lung inflammation compared with instillation. The conclusions drawn from the findings of the three subchronic inhalation studies discussed above clearly demonstrate the toxic potency of the various MWCNT samples tested, which produced adverse pulmonary effects in rats at low aerosol concentrations.
Predicting hazard effects of fiber-shaped particulates is likely to be more complicated than exposures to isometric particles because pulmonary toxicity of fibers is dependent on a number of general factors, including chemical composition, length dimension, respirability, and durability or biopersistence of the substance following deposition in the distal lung. The World Health Organization defines a respirable fiber as a particulate with a minimum aspect ratio of 3:1, that is, a length dimension greater than 5 µm, and a diameter less than 3 µm (WHO, 1997). Fiber dimension strongly influences the dose delivered to the alveolar regions of the lung and also may impact the biopersistence kinetics in the lung as well as enhancing biological reactivity. Based on the well-developed experience with asbestos fibers, the fiber toxicity paradigm is a predictive concept, which postulates that following repeated inhalation exposures of long, thin, and biopersistent fiber types are likely to produce pathogenic pulmonary effects. CNTs have physicochemical characteristics that emulate, in part, the necessary prerequisites associated with the fiber paradigm. CNTs clearly are very thin, biopersistent, and have high aspect ratios, but do not have the inherent length dimensions that are known to be characteristic of pathogenic amphibole asbestos fibers. In addition, CNTs also have substantial measured BET specific areas (i.e., > 250 m 2 /g), which likely play a role in mediating toxicity mechanisms. When assessing the applicability of the VGCF-H test substance with respect to the fiber paradigm, one might conclude that these materials do not conform to the basic tenets of the fiber paradigm. Although the CNFs are of a respirable size dimension, other material characterization characteristics of the nanofiber, evidenced by the relatively short fiber length (~5.8 µm), reduced surface area (13.8 m 2 /g vs. > 250 m 2 /g for CNTs), lack of inflammatory/cytotoxic effects at 2.5 mg/m 3 , and limited inflammatory responses (12% PMNs) at the highest concentration tested (25 mg/m 3 ), suggest a much less potent effect than would be expected from a HARN-type fiber.
The toxicology database for CNFs is very limited. Although a short-term inhalation toxicity study with pitch-based, respirable-sized carbon fibers was conducted many years ago (Warheit et al., 1994) , there have been limited inhalation toxicity studies with respirable CNFs in the scientific literature. Moreover, given the disparity between the relatively (more) extensive hazard information available on CNTs versus the paucity of data 458 DELORME ET AL. available for CNFs, it is quite surprising that NIOSH, in their guidance, recommended identical exposure limit values (recommended exposure limit [REL] , 7 µg/m 3 ) for these two nanomaterial types (NIOSH, 2010) . Justification for NIOSH's REL for CNF apparently was based on a single in vitro genotoxicity study as well as the results of a preliminary lung aspiration study with mice, demonstrating acute pulmonary inflammation and early onset of fibrosis in comparing samples of CNF with SWCNT and asbestos fibers (Kisin et al., 2010 (Kisin et al., , 2011 .
In attempting to discern possible mechanistic differences between CNT and CNF effects in the lung, Sanchez et al. (2009) have suggested that CNT exposures induced a mixed inflammatory cell population response of neutrophils and macrophages concomitant with the formation of multinucleated giant cells. These investigators have contrasted the responses of CNF with CNT, suggesting that CNFs produce primarily a macrophage-type response. The results of our 90-day inhalation study with CNFs appear to be in agreement with this assessment, as we determined that > 90% of lavaged alveolar macrophages contained CNF at the 2.5 and 25 mg/m 3 concentrations (indicating that the particulates are readily phagocytized by these cells), along with low levels of neutrophilic inflammation and cytotoxicity at the high dose; and no inflammation or cytotoxicity indices measured at 0.54 or 2.5 mg/m 3 . Other investigators have reported differences in toxicological endpoints when comparing in vitro or in vivo instillation effects of CNTs versus CNFs (Grabinsky et al., 2007; Lison and Muller, 2008) . Moreover, it has been proposed that CNT inflammatory responses could be driven initially by the development of frustrated (macrophage) phagocytosis by CNT deposited in the lung-perhaps related to aspect ratios, surface area, or presence of metal catalysts (transition metals) versus less complex, CNF uptake by macrophages.
An attempt was made to define the physicochemical and toxicological activity of carbon allotropes by correlating material characterization of the CNF test substance with the biological responses obtained in this 90-day study. It is concluded that, on a mass basis, the potency differences between CNF and CNT can be explained, in part, by differences among physical properties of carbon allotropes. It is hypothesized that differential pulmonary effects between the two forms of carbon nanoparticulates are attributed to the following characteristics: (1) disparities in surface area measurements of CNF and CNT test samples; (2) differential immunological and inflammatory cell responses following particulate exposures (i.e., CNF: > 90% macrophage phagocytic responses, no inflammation or cytotoxicity at 0.54 or 2.5 mg/m [Pauluhn, 2010] and granulomatous lesions indicating mixed immune reactions in the lung to the MWCNT test substance); (3) presence of metal catalysts following production and synthesis of CNT versus CNF; and (4) increased aspect ratio of CNTs versus CNFs. The results of future studies are likely to better define the roles of physicochemical factors in producing toxicological effects among the different forms of carbon nanomaterials.
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